Curious to see your top suppliers emissions?
Book a demo for a pilot project
Kwang Dong Pharmaceutical Co., Ltd.
Pharmaceutical Preparation ManufacturingSouth Korea
Last verified 7 months agoekdp.com
Kwang Dong Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in South Korea (KR). Established in 1963, the company has made significant strides in developing innovative healthcare solutions, focusing on prescription medications, over-the-counter products, and health supplements.
With a strong presence in both domestic and international markets, Kwang Dong is renowned for its commitment to quality and efficacy. The company’s core offerings include traditional herbal medicines and modern pharmaceuticals, distinguished by their unique formulations and adherence to rigorous safety standards.
Kwang Dong has achieved notable recognition within the industry, positioning itself as a trusted name in healthcare. Its dedication to research and development continues to drive advancements, ensuring that it remains at the forefront of the pharmaceutical sector.
23
DitchCarbon score
-19 vs industry average
Kwang Dong Pharmaceutical Co., Ltd.’s score of 23 is lower than 36% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Kwang Dong Pharmaceutical Co., Ltd.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Kwang Dong Pharmaceutical Co., Ltd. yet.
Kwang Dong Pharmaceutical Co., Ltd.'s reported carbon emissions
Kwang Dong Pharmaceutical Co., Ltd., a pharmaceutical preparation manufacturer based in KR, has not publicly disclosed specific carbon emissions data for recent years. Consequently, detailed information regarding their Scope 1, 2, or 3 emissions is unavailable.
The company has also not yet outlined specific reduction targets or commitments, such as Science Based Targets initiative (SBTi) aligned goals or participation in initiatives like the Climate Pledge. Further information on their climate strategy and environmental performance would be beneficial for understanding their impact and future direction in the pharmaceutical industry.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Kwang Dong Pharmaceutical Co., Ltd.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Kwang Dong Pharmaceutical Co., Ltd. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Kwang Dong Pharmaceutical Co., Ltd.7 months ago
23
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more